Blood test may predict who loses dangerous belly fat after surgery

NCT ID NCT07564986

Completed Knowledge-focused Sponsor: Sercan YUKSEL, MD Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looked at 80 people with severe obesity who had sleeve gastrectomy surgery. Researchers measured a blood protein called resistin before surgery to see if it could predict how much harmful internal belly fat patients would lose. The goal is to find a simple blood test that helps doctors know who will get the biggest health benefits from the procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If resistin levels reliably predict internal fat loss, doctors might better identify which patients will benefit most from weight-loss surgery.
What could go wrong: This is a small, completed observational study, not a treatment trial. The findings may not apply to all patients or lead to any change in clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MORBID OBESITY REQUIRING BARIATRIC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

morbid obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MORBID OBESITY REQUIRING BARIATRIC SURGERY

Contacts and locations

Locations

Basaksehir Cam and Sakura City Hospital

Istanbul, Basaksehir, 34480, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.